Patents by Inventor Isabel Maria Fidalgo Dos Santos Silva Carvalho

Isabel Maria Fidalgo Dos Santos Silva Carvalho has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190216831
    Abstract: The present invention relates to antiviral compositions. The present invention also relates to compositions for use in the therapy of equine viral infections. In particular, the present invention relates to compositions comprising at least one anti-viral compound for use in a method of therapy of an equine viral infection and/or infection by an equine virus in an animal.
    Type: Application
    Filed: May 31, 2016
    Publication date: July 18, 2019
    Applicant: EQUIGERMINAL SA
    Inventors: Isabel Maria Fidalgo dos Santos Silva Carvalho, Alexandre Simao Vieira Pires
  • Publication number: 20180135017
    Abstract: The present disclosure describes a method and composition for enhancing the survival of hematopoietic stem cells, preferably CD34+ derived from human umbilical cord or peripheral blood, in hypoxic and serum-deprived conditions by cultivating the cells in medium containing lysophosphatidic acid, preferably further comprising a gel, namely a biomimetic gel.
    Type: Application
    Filed: January 12, 2018
    Publication date: May 17, 2018
    Applicant: Stemlab, S.A.
    Inventors: Lino da Silva Ferreira, Isabel Maria Fidalgo dos Santos Silva Carvalho
  • Patent number: 9868935
    Abstract: The present disclosure describes a method and composition for enhancing the survival of hematopoietic stem cells, preferably CD34+ derived from human umbilical cord or peripheral blood, in hypoxic and serum-deprived conditions by cultivating the cells in medium containing lysophosphatidic acid, preferably further comprising a gel, namely a biomimetic gel. The method and composition may be used in medicine or cosmetic application, in particular, in treatment of cardiac tissue and/or cardiac diseases, and/or in the treatment of wound healing namely diabetic wound healing.
    Type: Grant
    Filed: April 24, 2013
    Date of Patent: January 16, 2018
    Assignee: CRIOESTAMINAL, SAÚDE E TECNOLOGIA, SA.
    Inventors: Lino Da Silva Ferreira, Isabel Maria Fidalgo Dos Santos Silva Carvalho
  • Publication number: 20160367659
    Abstract: A composition comprising one or more peptides selected from the group consisting of SEQ ID NOs 1 to 76; and/or comprising one or more polynucleotide sequences encoding one or more of the peptides selected from the group consisting of SEQ ID NOs 1 to 76; and/or comprising one or more polynucleotide sequences selected from the group consisting of SEQ ID NOs 77 to 152.
    Type: Application
    Filed: December 19, 2014
    Publication date: December 22, 2016
    Applicant: EQUIGERMINAL SA
    Inventors: Isabel Maria Fidalgo dos Santos Silva CARVALHO, Alexandre Simao Vieira PIRES
  • Publication number: 20150139962
    Abstract: The present disclosure describes a method and composition for enhancing the survival of hematopoietic stem cells, preferably CD34+ derived from human umbilical cord or peripheral blood, in hypoxic and serum-deprived conditions by cultivating the cells in medium containing lysophosphatidic acid, preferably further comprising a gel, namely a biomimetic gel. The method and composition may be used in medicine or cosmetic application, in particular, in treatment of cardiac tissue and/or cardiac diseases, and/or in the treatment of wound healing namely diabetic wound healing.
    Type: Application
    Filed: April 24, 2013
    Publication date: May 21, 2015
    Applicant: CRIOESTAMINAL, SAÚDE E TECNOLOGIA, SA.
    Inventors: Lino Da Silva Ferreira, Isabel Maria Fidalgo Dos Santos Silva Carvalho